New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 18, 2013
17:33 EDTESRXExpress Scripts sees FY13 EPS $4.20-$4.30, consensus $4.20
Total adjusted claims are expected to grow 5% to 7% from 1,395.7 million adjusted claims reported in 2012 . Selling, general and administrative expense is expected to decline 8% to 10% from $2,365.9 million reported on an adjusted basis in 2012 and EBITDA per adjusted claim is expected to grow 15% to 18% from $3.87 reported on an adjusted basis in 2012.
News For ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
09:59 EDTESRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:27 EDTESRXExpress Scripts downgraded to Market Perform from Outperform at FBR Capital
Subscribe for More Information
January 21, 2015
10:28 EDTESRXLeerink pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
10:01 EDTESRXOn the Fly: Analyst Initiation Summary
Subscribe for More Information
07:36 EDTESRXExpress Scripts initiated with an Equal Weight at Stephens
Subscribe for More Information
January 20, 2015
06:44 EDTESRXExpress Scripts downgraded to Neutral from Buy at UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use